Liminatus Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LIMN and other ETFs, options, and stocks.About LIMN
Liminatus Pharma, Inc. is a pre-clinical-stage immuno-oncology company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in La Palma, CA.
LIMN Key Statistics
Stock Snapshot
The current Liminatus Pharma(LIMN) stock price is $1.58, with a market capitalization of 68.73M. The stock trades at a price-to-earnings (P/E) ratio of -9.92.
During the trading session on 2026-02-07, Liminatus Pharma(LIMN) shares reached a daily high of $2.63 and a low of $1.43. At a current price of $1.58, the stock is +10.5% higher than the low and still -39.9% under the high.
Trading volume for Liminatus Pharma(LIMN) stock has reached 48.78M, versus its average volume of 32.03M.
Over the past 52 weeks, Liminatus Pharma(LIMN) stock has traded between a high of $33.66 and a low of $0.54.
Over the past 52 weeks, Liminatus Pharma(LIMN) stock has traded between a high of $33.66 and a low of $0.54.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.